Study: BIRC2 overexpression could be a key marker for immunotherapy resistance

[News]

Johns Hopkins Medicine researchers have added to evidence that a gene responsible for turning off a cell's natural "suicide" signals may also be the culprit in making breast cancer and melanoma cells resistant to therapies that use the immune system to fight cancer.

More... (https://www.news-medical.net/news/20200902/Study-BIRC2-overexpression-could-a-key-marker-for-immunotherapy-resistance.aspx)